0001628280-26-015153
SEC filingOmada Health reported Q4 2025 revenue of $76 million (up 58% YoY) and full-year revenue of $260 million (up 53% YoY), achieving positive net income of $5 million in Q4 and positive Adjusted EBITDA of $6 million for the year. The company issued 2026 guidance for revenue of $312-322 million and Adjusted EBITDA of $7-15 million.